Gene · 23210
Papers1,476
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,476
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunohistological Evaluation of Peri-Implant Soft Tissue Grafting Using a Porcine Dermal Matrix-A Human Histological Study. | Clin Oral Implants Res | 2026 | 41612880 | PubTator, text mining | PubMed |
| Does extracellular vesicle specificity truly exist? | Cell Commun Signal | 2026 | 41593667 | PubTator, text mining | PubMed |
| Epigenetically-controlled CEBPB regulates kidney cancer tumorigenesis via GPD1L-mediated ether lipid synthesis. | Cell Death Dis | 2026 | 41565622 | PubTator, text mining | PubMed |
| Comparative proteomic analysis of the ECM composition of the human omentum and mesentery, the main sites of ovarian cancer metastasis. | iScience | 2026 | 41550748 | PubTator, text mining | PubMed |
| Cardiopathogenic T Cells Govern Progression and Functional Remodeling in Inflammatory Cardiomyopathy and Chronic Myocarditis. | JACC Basic Transl Sci | 2026 | 41529645 | PubTator, text mining | PubMed |
| A Histone Code Functionally Linked to Replicative Senescence. | Aging Cell | 2026 | 41482664 | PubTator, text mining | PubMed |
| Unlocking binding properties of single-domain antibodies targeting the polymeric immunoglobulin receptor to enhance mucosal enrichment of IgG against respiratory syncytial virus. | Front Immunol | 2025 | 41737496 | PubTator, text mining | PubMed |
| Exploiting Oxidative Stress as Achilles' Heel: From Redox Homeostasis to Ferroptosis in Prostate Cancer. | Antioxidants (Basel) | 2025 | 41462716 | PubTator, text mining | PubMed |
Perceived satisfaction, perceived usefulness, and interactive learning environments as predictors of university students' self-regulation in the context of GenAI-assisted learning: an empirical study in mainland China. | Front Psychol | 2025 | 41446605 | PubTator, text mining | PubMed |
| Enhancer/Enhanceosome/Super-enhancer and the promoter-proximate RNA Polymerase II (Pol II) pausing are coupled. | bioRxiv | 2025 | 41427291 | PubTator, text mining | PubMed |
| High-throughput in silico screen uncovers key regulators of 3D genome architecture. | bioRxiv | 2025 | 41415375 | PubTator, text mining | PubMed |
| Overexpression of JMJD6 drives immune evasion via the BRD4-IRF1-PD-L1 axis and promotes malignancy in gastric cancer. | Sci Rep | 2025 | 41360913 | PubTator, text mining | PubMed |
| Integrative analysis of non-small cell lung cancer identifies Jumonji domain-containing 6/ETS homologous factor axis as a target to overcome radioresistance. | Signal Transduct Target Ther | 2025 | 41320721 | PubTator, text mining | PubMed |
| Optimizing hole transport efficiency in perovskite solar cells by structural modeling of 1,4-dihydropyrrolo[3,2-b]pyrroles with various donors: a DFT approach. | RSC Adv | 2025 | 41306886 | PubTator, text mining | PubMed |
| Proteome-Wide Monitoring of Drug Action in Living Cells Using a Novel Label-Free Solvent-Based Shift Assay. | Mol Cell Proteomics | 2025 | 41202878 | PubTator, text mining | PubMed |
| Profiling Inhibitor Scaffolds for the Cancer Target Jumonji-C Domain-Containing Protein 6. | ChemMedChem | 2025 | 41170613 | PubTator, text mining | PubMed |
| Tumor Microenvironment T-cell Heterogeneity and Prognostic Model Construction in Laryngeal Squamous Cell Carcinoma by Single-cell and Bulk RNA Sequencing. | Comput Methods Biomech Biomed Engin | 2025 | 41066764 | PubTator, text mining | PubMed |
| A clarifying perspective on bacterial pseudo-receiver domains. | J Bacteriol | 2025 | 41060066 | PubTator, text mining | PubMed |
| Targeting JMJD6/PPARγ/GPX4 axis overcomes ferroptosis resistance and enhances therapeutic efficacy in hepatocellular carcinoma. | Oncogene | 2025 | 41028904 | PubTator, text mining | PubMed |
| Genetic susceptibility to oral and atherosclerotic cardiovascular diseases based on dental and heart SCORE studies. | Sci Rep | 2025 | 41006734 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23210/papers?page=2